Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 19/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 19/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5508112 | 0.83 | ESR1 (0.63) | ESR1ESR2HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL30765144 | 0.79 | ESR1 (0.58) | ESR1ESR2HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL745847 | 0.79 | ESR1 (0.62) | ESR1ESR2HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL16360885 | 0.79 | ESR1 (0.58) | ESR1ESR2HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL1836503 | 0.79 | ALDH1A1 (0.49) | ESR1ESR2HSP90AA1ALDH1A1MAPT | |
| SCHEMBL8290795 | 0.79 | ESR1 (0.41) | ESR1ESR2HSP90AA1 | |
| SCHEMBL5512412 | 0.79 | ESR1 (0.42) | ESR1ESR2HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL5514251 | 0.79 | ACHE (0.41) | ESR1ESR2HSP90AA1 | |
| SCHEMBL1101176 | 0.79 | ESR1 (0.45) | ESR1ESR2HSP90AA1MAPTALOX15 | |
| SCHEMBL3932748 | 0.76 | ESR1 (1.00) | ESR1ESR2HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313704-A1 | ALGICIDAL ORGANISMS | PRO FARM GROUP, INC. | 2025-10-09 | — | — | US | disclosed |
| US-20250287954-A1 | METHOD AND COMPOSITION OF SYNERGISTIC INSECTICIDAL MIXTURES | PRO FARM GROUP, INC. | 2025-09-18 | — | — | US | disclosed |
| EP-4514135-A1 | METHOD AND COMPOSITION OF SYNERGISTIC INSECTICIDAL MIXTURES | Pro Farm Group, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| CN-119173143-A | Methods and compositions for synergistic insecticidal mixtures | 专业农场集团有限公司 | 2024-12-20 | — | — | CN | disclosed |
| WO-2023212708-A9 | METHOD AND COMPOSITION OF SYNERGISTIC INSECTICIDAL MIXTURES | PRO FARM GROUP, INC. (US) | 2024-02-22 | — | — | WO | disclosed |
| EP-3537878-B1 | ALGICIDAL ORGANISMS | PRO FARM GROUP INC (US) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023212708-A1 | METHOD AND COMPOSITION OF SYNERGISTIC INSECTICIDAL MIXTURES | PRO FARM GROUP, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-20210282405-A1 | ALGICIDAL ORGANISMS | MARRONE BIO INNOVATIONS, INC. (US) | 2021-09-16 | — | — | US | disclosed |
| US-20210274791-A1 | COMPOSITIONS AND METHODS TO TREAT CITRUS GREENING DISEASE | MARRONE BIO INNOVATIONS, INC. (US) | 2021-09-09 | — | — | US | disclosed |
| WO-2013130680-A1 | CONTROL OF PHYTOPATHOGENIC MICROORGANISMS WITH PSEUDOMONAS SP. AND SUBSTANCES AND COMPOSITIONS DERIVED THEREFROM | MARRONE BIO INNOVATIONS, INC. (US) | 2013-09-06 | — | — | WO | disclosed |
| US-20120100236-A1 | CHROMOBACTERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | MARRONE BIO INNOVATIONS, INC. (US) | 2012-04-26 | — | — | US | disclosed |
| US-20100028469-A1 | Extracts of Cranberry and Methods of Using Thereof | HERBALSCIENCE GROUP, LLC (US) | 2010-02-04 | — | — | US | disclosed |
| US-7166725-B2 | Benzo[d]isoxazol-3-ol DAAO inhibitors | SEPRACOR INC. (US) | 2007-01-23 | — | — | US | disclosed |
| US-7166725-B2 | Benzo[d]isoxazol-3-ol DAAO inhibitors | SEPRACOR INC. (US) | 2007-01-23 | — | — | US | disclosed |
| US-7166725-B2 | Benzo[d]isoxazol-3-ol DAAO inhibitors | SEPRACOR INC. (US) | 2007-01-23 | — | — | US | disclosed |
| EP-1711478-A2 | BENZO [D]ISOXAZOL-3-OL DAAO INHIBITORS | Sepracor Inc. (US) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005066143-A2 | BENZO[D]ISOXAZOL-3-OL DAAO INHIBITORS | SEPRACOR INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005066143-A2 | BENZO[D]ISOXAZOL-3-OL DAAO INHIBITORS | SEPRACOR INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143434-A1 | Benzo[d]isoxazol-3-ol DAAO inhibitors | SEPRACOR INC. (US) | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143434-A1 | Benzo[d]isoxazol-3-ol DAAO inhibitors | DDO, DAO, CACNA1S | ESR1 2250/4885ESR2 3052/4885HSP90AA1 3107/4885 |
| US-20250287954-A1 | METHOD AND COMPOSITION OF SYNERGISTIC INSECTICIDAL MIXTURES | CRYAB, CRYAA, STXBP1 | ESR1 4294/4885ESR2 3116/4885HSP90AA1 510/4885 |
| US-20120100236-A1 | CHROMOBACTERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | CBX3, CBX7, CBX6 | ESR1 2916/4885ESR2 3157/4885HSP90AA1 2865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.